Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion, Science, vol.331, 2011. ,
Natural innate and adaptive immunity to cancer, Annu Rev Immunol, vol.29, pp.235-71, 2011. ,
Regulatory T cells: mechanisms of differentiation and function, Annu Rev Immunol, vol.30, pp.531-64, 2012. ,
Molecular mechanisms of tregmediated T cell suppression, Front Immunol, vol.3, p.51, 2012. ,
Multiple treg suppressive modules and their adaptability, Front Immunol, vol.3, p.178, 2012. ,
Prognostic significance of regulatory T cells in tumor, Int J Cancer, vol.127, pp.748-58, 2010. ,
Differences in tumor regulatory T-cell localization and activation status impact patient outcome, Cancer Res, vol.69, pp.7895-7903, 2009. ,
Tumor-infiltrating FOXP3C T regulatory cells show strong prognostic significance in colorectal cancer, J Clin Oncol, vol.27, pp.186-92, 2009. ,
Correlation of high numbers of intratumoral FOXP3C regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma, Haematologica, vol.93, pp.193-200, 2008. ,
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival, Nat Med, vol.10, pp.942-951, 2004. ,
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection, J Clin Oncol, vol.25, pp.2586-93, 2007. ,
FOXP3C regulatory T cells affect the development and progression of hepatocarcinogenesis, Clin Cancer Res, vol.13, pp.902-913, 2007. ,
Localisation pattern of Foxp3C regulatory T cells is associated with clinical behaviour in gastric cancer, Br J Cancer, vol.98, pp.148-53, 2008. ,
Tumor infiltrating Foxp3C regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer, vol.107, pp.2866-72, 2006. ,
Association of cervical cancer with the presence of CD4C regulatory T cells specific for human papillomavirus antigens, Proc Natl Acad Sci, vol.104, pp.12087-92, 2007. ,
The role of human papillomaviruses in human cancers, Front Biosci, vol.7, pp.641-650, 2002. ,
Rapamycin impairs antitumor CD8C T-cell responses and vaccine-induced tumor eradication, Cancer Res, vol.75, pp.3279-91, 2015. ,
Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system, Cancer Res, vol.67, pp.8847-55, 2007. ,
The T-cell receptor repertoire of tumor-infiltrating regulatory T lymphocytes is skewed toward public sequences, Cancer Res, vol.72, pp.3557-69, 2012. ,
Depletion of CD4C T cells in major histocompatibility complex class II-deficient mice, Science, vol.253, pp.1417-1437, 1991. ,
Regulatory function of CD4CCD25C T cells from Class II MHC-deficient mice in contact hypersensitivity responses, J Leukocyte Biol, vol.82, pp.85-92, 2007. ,
Functional adaptive CD4 Foxp3 T cells develop in MHC class II-deficient mice, J Immunol, vol.177, pp.8307-8321, 2006. ,
CD103 is a hallmark of tumor-infiltrating regulatory T cells, Int J Cancer, vol.129, pp.2417-2443, 2011. ,
CD4CCD25C T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion, J Exp Med, vol.199, pp.1479-89, 2004. ,
Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells, J Allergy Clin Immunol, vol.126, pp.1-7, 2010. ,
PD-1 and its ligands in tolerance and immunity, Annu Rev Immunol, vol.26, pp.677-704, 2008. ,
The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies, J Hematol Oncol, vol.6, p.74, 2013. ,
Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3C T reg cells, J Exp Med, vol.209, pp.1723-1765, 2012. ,
Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo, J Exp Med, vol.209, pp.1713-1735, 2012. ,
Neuropilin-1 is not a marker of human Foxp3C Treg, Eur J Immunol, vol.39, pp.1466-71, 2009. ,
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer, N Eng J Med, vol.366, pp.2443-54, 2012. ,
Mice lacking all conventional MHC class II genes, Proc Natl Acad Sci U S A, vol.96, pp.10338-10381, 1999. ,
Effect of attenuation of Treg during BCG immunization on anti-mycobacterial Th1 responses and protection against Mycobacterium tuberculosis, PLoS One, vol.3, p.2833, 2008. ,
Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells, Clin Cancer Res, vol.12, pp.4294-305, 2006. ,
Cyclophosphamide induces a type I interferon-associated sterile inflammatory response signature in cancer patients' blood cells: implications for cancer chemoimmunotherapy, Clin Cancer Res, vol.19, pp.4249-61, 2013. ,
Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer, Blood, vol.95, pp.2024-2054, 2000. ,
Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis, Cancer Res, vol.71, pp.768-78, 2011. ,
Metronomic cyclophosphamide regimen selectively depletes CD4CCD25C regulatory T cells and restores T and NK effector functions in end stage cancer patients, Cancer Immunol Immunother, vol.56, pp.641-649, 2007. ,
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth, Nat Med, vol.19, pp.57-64, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00919371
Immunotherapy and chemotherapy-a practical partnership, Nat Rev Cancer, vol.5, pp.397-405, 2005. ,
Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells, Immunity, vol.38, pp.729-770, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02047416
ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy, Oncoimmunology, vol.2, p.24568, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02047415
Combining immunotherapy with chemotherapy to treat cancer, Trial Watch: Anticancer radioimmunotherapy. Oncoimmunology, vol.2, pp.265-70, 2005. ,
Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer, Immunity, vol.39, pp.782-95, 2013. ,
Concurrent infiltration by CD8C T cells and CD4C T cells is a favourable prognostic factor in non-small-cell lung carcinoma, Br J Cancer, vol.94, pp.275-80, 2006. ,
Effector memory T cells, early metastasis, and survival in colorectal cancer, N Engl J Med, vol.353, pp.2654-66, 2005. ,
The essential role of the in situ immune reaction in human colorectal cancer, J Leukocyte Biol, vol.84, pp.981-988, 2008. ,
Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer, Cancer Res, vol.71, pp.1263-71, 2011. ,
Coordinated regulation of myeloid cells by tumours, Nat Rev Immunol, vol.12, pp.253-68, 2012. ,
Regulatory T cells prevent CD8 T cell maturation by inhibiting CD4 Th cells at tumor sites, J Immunol, vol.179, pp.4969-78, 2007. ,
Immune enhancement of skin carcinogenesis by CD4C T cells, J Exp Med, vol.197, pp.1017-1045, 2003. ,
Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer, J Hepatol, vol.47, pp.807-822, 2007. ,
Anti-PD-1 synergizes with cyclophosphamide to induce potent anti-tumor vaccine effects through novel mechanisms, Eur J Immunol, vol.41, pp.2977-86, 2011. ,
A novel dendritic cell targeting HPV16 E7 synthetic vaccine in combination with PD-L1 blockade elicits therapeutic antitumor immunity in mice, Oncoimmunology, vol.5, p.1147641, 2016. ,
B cells promote tumor progression in a mouse model of HPV-mediated cervical cancer, Int J Cancer, vol.139, pp.1358-71, 2016. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01942430
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints, Nat Commun, vol.7, p.10501, 2016. ,
Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer, Oncoimmunology, vol.6, p.1249561, 2017. ,
Tlymphocyte-epithelial-cell interactions: integrin alpha(E)(CD103)beta (7), LEEP-CAM and chemokines, Curr Opin Cell Biol, vol.12, pp.563-571, 2000. ,
Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells, Cell, vol.164, pp.365-77, 2016. ,
Induction of resident memory T cells enhances the efficacy of cancer vaccine, Nat Commun, vol.8, p.15221, 2017. ,
T-bet(C) Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor beta2, Immunity, vol.37, pp.501-511, 2012. ,
The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation, Nat Immunol, vol.10, pp.595-602, 2009. ,
Dynamic expression of transcription factors T-bet and GATA-3 by regulatory T cells maintains immunotolerance, Nat Immunol, vol.16, pp.197-206, 2015. ,
Anti-GITR agonist therapy intrinsically enhances CD8 T cell responses to chronic lymphocytic choriomeningitis virus (LCMV), thereby circumventing LCMV-induced downregulation of costimulatory GITR ligand on APC, J Immunol, vol.193, pp.5033-5076, 2014. ,
Enhancement of CD8C T cell responses by ICOS/B7 h costimulation, J Immunol, vol.167, pp.132-141, 2001. ,
In vivo receptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11 c C CD8 alpha -CD11bhigh dendritic cells, Eur J Immunol, vol.32, pp.3071-81, 2002. ,
Th2 lymphoproliferative disorder of LatY136 F mutant mice unfolds independently of TCR-MHC engagement and is insensitive to the action of Foxp3C regulatory T cells, J Immunol, vol.180, pp.1565-75, 2008. ,
Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen, Cancer Res, vol.56, pp.21-27, 1996. ,
Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein, Cancer Res, vol.65, pp.641-650, 2005. ,